●Keeping the lock on smallpox. Weiner, D. B. Nature Medicine September (2003)

●Drug discovery: In the eye of the beholder? Pearson, H. Nature 28 August (2003) This News Feature assesses the potential impact of 'cosmeceuticals' on the pharma industry.

●The production of recombinant pharmaceutical proteins in plants. Ma, J. K.-C., Drake, P. M. W. & Christou, P. Nature Reviews Genetics October (2003)

●Cannabinoids: potential anticancer agents. Guzmán, M. Nature Reviews Cancer October (2003)

●What doesn't kill you makes you stronger. Hadley, C. EMBO Reports October (2003) This Analysis asserts that a new model for risk assessment will revolutionize the field of toxicology and have implications for risk assessment.

●Clinical implications of pharmacogenetics for glaucoma therapeutics. McLaren, N. C. & Moroi, S. E. The Pharmacogenomics Journal August (2003)

●Malaria: To kill a parasite. Ridley, R. G. Nature 21 August (2003) A new theory might explain how the ancient medicaments artemisinins incapacitate Plasmodium species.

●Sensing microbes by diverse hosts. Workshop on pattern recognition proteins and receptors. Girardin, S. E., Philpott, D. J. & Lemaitre, B. EMBO Reports October (2003)

●Affective disorders, antidepressant drugs and brain metabolism. Moretti, A., Gorini, A. & Villa, R. F. Molecular Psychiatry September (2003)

●Learning from the gut. Mattson, M. P., Perry, T. & Greig, N. H. Nature Medicine September (2003) According to this News & Views article, the discovery that glucagon-like peptide-1 can enhance learning and memory makes it a novel target for the prevention and treatment of neuronal degeneration.

●Inaugural issue: Nature Reviews Microbiology October (2003)

●Where will new antibiotics come from? Walsh, C.

●Inhibiting sexual transmission of HIV-1 infection. Shattock, R. J. & Moore, J. P.